![](/img/cover-not-exists.png)
Rationale and design of an investigator-initiated, multicenter, prospective open-label, randomized trial to evaluate the effect of ipragliflozin on endothelial dysfunction in type 2 diabetes and chronic kidney disease: the PROCEED trial
Tanaka, Atsushi, Shimabukuro, Michio, Okada, Yosuke, Sugimoto, Kazuhiro, Kurozumi, Akira, Torimoto, Keiichi, Hirai, Hiroyuki, Node, KoichiVolume:
19
Journal:
Cardiovascular Diabetology
DOI:
10.1186/s12933-020-01065-w
Date:
December, 2020
File:
PDF, 917 KB
2020